60 Biggest Movers From Yesterday

Gainers

• Bone Biologics Corporation BBLG shares surged 57.1% to close at $5.39 on Monday.
• Zynga Inc. ZNGA rose 40.7% to settle at $8.44 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion.
• Molecular Partners AG MOLN surged 30.5% to settle at $21.50 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.
• Reliance Global Group, Inc. RELI climbed 28.9% to close at $7.86. Reliance Global Group, last month, announced pricing of $20.0 million private placement with institutional investors.
• RxSight, Inc. RXST gained 28.2% to settle at $11.50 after the company late Sunday issued preliminary Q4 and FY21 guidance above estimates.
• BioCryst Pharmaceuticals, Inc. BCRX jumped 27.9% to close at $14.78 after the company announced preliminary, unaudited ORLADEYO revenue for Q4 and FY21 and provided new guidance for full year 2022 ORLADEYO net revenue and expected peak ORLADEYO sales.
• iRhythm Technologies, Inc. IRTC surged 27.6% to settle at $130.04.
• Adamis Pharmaceuticals Corporation ADMP rose 27% to close at $0.73 after the company announced the submission of a Fast Track Application to the FDA for Tempol for the treatment and prevention of COVID-19.
• Apria, Inc. APR shares gained 26.1% to close at $37.48. Owens & Minor agreed to acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion.
• Discovery, Inc. DISCB climbed 25.5% to close at $44.50. The company, along with AT&T, recently won a favorable ruling from the Internal Revenue Service for the planned merger between the company and AT&T's WarnerMedia entertainment business.
• Pluristem Therapeutics Inc. PSTI jumped 24.5% to close at $1.83. Pluristem Therapeutics and Tnuva Group have collaborated to develop, manufacture and commercialize cultured cell-based products for the food industry.
• Olink Holding AB OLK rose 23.8% to settle at $14.46. Olink said it sees Q4 sales of $43.2 million to $43.7 million and expects FY21 sales of $94.5 million to $95 million.
• Biofrontera Inc. BFRI gained 22% to close at $6.26.
• Immunic, Inc. IMUX jumped 19.2% to settle at $11.49.
• Apyx Medical Corporation APYX shares rose 19.1% to settle at $12.98. Apyx Medical Corporation sees preliminary Q4 sales of $16.3 million to $16.8 million, up 42% year over year.
• CareDx, Inc CDNA shares jumped 18.5% to close at $46.29 after the company issued strong sales forecast.
• G Medical Innovations Holdings Ltd GMVD jumped 17.3% to close at $2.64. McDade Products, LLC joined forces with G Medical Tests and Services to provide U.S. retailers with millions of COVID-19 at-home PCR test kits.
• Lixte Biotechnology Holdings, Inc. LIXT gained 16.8% to settle at $2.50.
• Lucira Health, Inc. LHDX rose 15.6% to close at $8.29 after the company issued strong sales forecast for the fourth quarter.
• Treace Medical Concepts, Inc. TMCI gained 14.9% to close at $20.25. Treace Medical Concepts sees Q4 sales of $33.100 million to $33.400 million.
• Odonate Therapeutics, Inc. ODT surged 14.7% to settle at $1.25. Odonate Therapeutics recently received notice from The Nasdaq Stock Market that the continued listing of its securities is no longer warranted.
• Century Therapeutics, Inc. IPSC gained 14.5% to close at $15.14. Century Therapeutics and Bristol Myers Squibb have announced a research collaboration and license agreement for up to four induced pluripotent stem cell (iPSC) programs for hematologic malignancies and solid tumors.
• Venus Concept Inc. VERO jumped 13.8% to settle at $1.82. Venus Concept sees Q4 sales of $32 million to $33 million.
• Tilray, Inc. TLRY gained 13.6% to close at $7.29 after the company announced fiscal second-quarter 2022 financial results showing revenue increased year-over-year and the company reached profitability.
• Immix Biopharma, Inc. IMMX rose 12.7% to close at $6.02.
• Arco Platform Limited ARCE shares gained 10.1% to settle at $20.55.
• Jazz Pharmaceuticals plc JAZZ jumped 9% to settle at $146.49 after the company announced its Vision 2025 expectations.

Check out these big penny stock gainers and losers

Losers

• TDH Holdings, Inc. PETZ shares tumbled 81.9% to close at $0.74 on Monday. TDH Holdings, last month, reported H1 revenue of $130,000.
• OneSmart International Education Group Limited ONE fell 33.1% to close at $0.1941 after gaining more than 5% on Friday.
• Kidpik Corp. PIK fell 27.5% to settle at $4.75. Kidpik, last month, posted a Q3 loss of $0.22 per share.
• Torrid Holdings Inc. CURV fell 22.4% to close at $8.20 after the company lowered its Q4 revenue guidance.
• Rapid Micro Biosystems, Inc. RPID fell 21.2% to close at $7.20. Rapid Micro Biosystems said it expects Q4 total revenue of between $4.7 and $5.2 million.
• China HGS Real Estate Inc. HGSH fell 21% to close at $2.75 after jumping over 57% on Friday.
• Marin Software Incorporated MRIN dipped 19% to close at $3.67. Marin Software shares jumped 31% on Friday after the company announced an integration with Amazon Ads' demand-side platform.
• eMagin Corporation EMAN fell 18.9% to settle at $1.46.
• Elite Education Group International Limited EEIQ tumbled 18.4% to close at $2.40.
• Bird Global, Inc. BRDS fell 17.6% to close at $6.81.
• Excellon Resources Inc. EXN dropped 17.5% to settle at $0.7706.
• Marpai, Inc. MRAI shares dropped 17.2% to close at $2.92.
• Amicus Therapeutics, Inc. FOLD fell 17.2% to close at $9.45. Amicus Therapeutics said it sees FY21 Galafold sales of $306 million.
• ATA Creativity Global AACG fell 17.1% to settle at $2.19 after jumping more than 33% on Friday.
• The Beauty Health Company SKIN dropped 16.7% to close at $18.46. Beauty Health expects FY21 sales around the high end of prior guidance of $245 million to $255 million.
• Pixelworks, Inc. PXLW fell 16.6% to close at $3.43.
• Citi Trends, Inc. CTRN shares fell 16.3% to close at $67.89. Citi Trends reported 2021 holiday sales results and updated long-term strategic plan.
• Nurix Therapeutics, Inc. NRIX tumbled 15.9% to close at $23.27.
• RAPT Therapeutics, Inc. RAPT dropped 15.8% to settle at $32.89.
• Energy Focus, Inc. EFOI fell 15.7% to settle at $2.89.
• Digital Brands Group, Inc. DBGI dropped 15.2% to close at $1.96.
• Hour Loop, Inc. HOUR declined 14.8% to close at $6.81. The company’s stock jumped around 100% on Friday after the company priced its IPO at $4 per share.
• Eliem Therapeutics, Inc. ELYM shares fell 14.7% to close at $9.43.
• Take-Two Interactive Software, Inc. TTWO dropped 13.1% to close at $142.99 after the company announced it will acquire all of the outstanding shares of Zynga in a cash and stock transaction valued at $9.861 per Zynga share, with a total enterprise value of approximately $12.7 billion.
• Team, Inc. TISI fell 12.8% to close at $1.02.
• Zhangmen Education Inc. ZME fell 12.5% to close at $1.88.
• CinCor Pharma, Inc. CINC fell 11.7% to settle at $14.13. The company, on Friday, priced its IPO at $16 per share.
• Quoin Pharmaceuticals, Ltd. QNRX fell 11.1% to close at $1.85.
• Cyngn Inc. CYN fell 10.5% to close at $3.25. Cyngn said Global Logistics and Fulfillment LLC has engaged the company as its exclusive autonomous vehicle solutions provider.
• Vigil Neuroscience, Inc. VIGL fell 9.8% to settle at $11.41. The company, on Friday, priced its IPO at $14 per share.
• Arcadia Biosciences, Inc. RKDA shares fell 7.9% to settle at $1.05 after climbing around 12% on Friday.
• GameStop Corp. GME dropped 6.7% to close at $131.15 amid overall market weakness following a rise in yields as well as continued Fed tapering concerns for 2022.
• Fangdd Network Group Ltd. DUO fell 6.1% to close at $0.3493. FangDD, on Friday, received Nasdaq notice regarding minimum bid requirements.